Med Tech Consulting & Testing

Consultants offer guidance by evaluating processes and deriving specific recommendations for action. Consultants can help to set up MDR-compliant technical documentation, introduce a quality management system (QMS) in accordance with ISO 13485, or establish structured risk management processes. Inspections and audits create transparency about the status of compliance: Where are the gaps, what evidence is missing and what corrective measures make sense? Especially for small and medium-sized med tech companies, external support can be an important lever for targeting resources and reducing risks. 

Consulting and testing are key components for safe and marketable products because they bridge the gap between technical solutions and regulatory approval. Healthcare technology must not only function properly, but also be demonstrably safe and must be developed, manufactured, and monitored in such a way that risks are controlled. 

The development and manufacture of devices are significantly influenced by legal and normative requirements. In Europe, the MDR (EU) 2017/745 is the central framework. Among other things, it defines requirements for safety and performance, classification rules, conformity assessment procedures, clinical evaluation, technical documentation, UDI (Unique Device Identification) systems and post-market surveillance, vigilance. In addition, standards that are considered “state of the art” and support verification are also relevant. ISO 13485, which describes requirements for quality management systems, plays a key role. In practice, ISO 13485 is often the basis for processes such as design controls, supplier management, document control, CAPA (Corrective and Preventive Actions), risk management, and internal audits. 

The international regulatory market is more heterogeneous. Companies that operate globally must take regulatory differences into account and align their strategies accordingly. In addition to Europe, the most important markets include the US, China, Japan, Canada, Australia, and, increasingly, markets in the Middle East and Southeast Asia. In the US, the US Food and Drug Administration (FDA) is responsible. In many regions, regulations for software as a medical device (SaMD) and cybersecurity requirements are also gaining in importance. While legal requirements vary from market to market, ISO 13485 is a key reference point in many countries: it is recognized in numerous approval and audit processes or used as a basis, even if additional national requirements apply. 

A look at Europe shows that, in addition to the MDR, guidelines from the Medical Device Coordination Group (MDCG), harmonized standards, the role of notified bodies, and clinical evidence requirements have a particular impact on the handling. Companies must provide verifiable evidence that the technology meets the essential safety and performance requirements. This includes systematic risk management, evaluation based on appropriate data, robust technical documentation, and a functioning quality management.  

A fundamental understanding of the MDR and relevant standards is important for all market participants because regulation affects many areas of value creation: from product concept and design to the supply chain and market surveillance. Those who take requirements into account at an early stage can reduce development risks, avoid rework, and make approval processes more efficient. Conversely, knowledge gaps often lead to delays, for example, when documentation is incomplete, data is insufficient, or quality management processes are not documented in an audit-proof manner. 

The requirements and quality management are key elements for safety, verification, and market access. A QMS in accordance with ISO 13485 creates the organizational basis for systematically implementing regulations: responsibilities are defined and documented, changes are controlled, deviations are processed, and corrective measures are tracked. This increases consistency in development and production and supports compliance with legal requirements. At the same time, robust quality management enables clear communication with notified bodies, authorities, partners, and customers. For healthcare companies, this is not only a formal obligation, but also a factor that strengthens trust and can reduce costs in the long term. 

Visitors to COMPAMED will find a concentrated range of specialist knowledge, services, and contacts along the value chain. In an industry where development times, approval requirements, and market demands are closely interlinked, direct exchange with experts can help to plan projects more effectively and identify risks at an early stage. 

The focus is typically on topics such as MDR and ISO 13485 implementation, technical documentation, evaluation, risk management, usability engineering, validation and verification, as well as supplier and process qualification. In addition, data protection and information security are becoming increasingly important, especially for networked products and software solutions. At COMPAMED, med tech companies can find out about consulting approaches that include gap analyses, process design, training, and audit support. Depending on the provider, testing services range from material and component testing to electrical safety, EMC testing, biocompatibility assessments, software testing, and system validation. 

Experts from consulting, testing, approval, and quality management contribute practical knowledge that goes beyond mere legal texts. Comparisons are particularly valuable: companies can directly compare different service profiles, specializations, and approaches. 

COMPAMED is an important point of contact for med tech companies seeking consulting or testing services: 

Especially when it comes to complex issues, such as selecting suitable testing methods, planning clinical evidence, or setting up a QMS, it helps to talk to several providers and compare offers. 

Instead of holding many individual meetings over several weeks, teams can clarify requirements, define service scopes, and coordinate initial project approaches in just a few days.  

In face-to-face meetings, details regarding experience, certifications, capacities, international coverage, and project methodology can be better assessed than in documents alone.